| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.6 / 5 (436) | Istanbul, Turkey | 25+ years | Lutetium-177 therapy, targeted drugs | Advanced or metastatic cancers | JCI-accredited oncology department with access to advanced targeted drugs and personalized therapy plans. Follows NCCN and ESMO protocols for precise treatment. | International Organization for Standardization, Joint Commission International | ||
| #2 | 4.6 / 5 (544) | Istanbul, Turkey | 33+ years | Lutetium-177 therapy, Actinium-225 therapy | Advanced prostate cancer with PSMA-targeted therapy | Offers specialized PSMA-targeted therapies with JCI accreditation and collaboration with Johns Hopkins Medicine. Doctors have 40+ publications in tumor biology and targeted therapy. | Planetree's Gold Certificate, International Accreditation System for Interventional Oncology Services (IASIOS) | ||
| #3 | 4.6 / 5 (165) | Istanbul, Turkey | 15+ years | Lutetium-177 therapy | Advanced cancer cases requiring precision treatment | Specializes in Lutetium-177 therapy with a dedicated targeted therapy team led by an experienced oncologist. Offers precise diagnostics with 3T MRI and innovative Elekta Versa HD radiotherapy system. | International Organization for Standardization, Joint Commission International | ||
| #4 | 4.5 / 5 (266) | Istanbul, Turkey | 20+ years | Lutetium-177 therapy | Metastatic colorectal cancer | JCI-accredited hospital with specialized oncology team. Offers Lutetium-177 therapy for targeted cancer treatment. Doctors recommend personalized treatment plans based on molecular test results. | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) | ||
| #5 | 4.8 / 5 (9) | Istanbul, Turkey | 14+ years | Actinium-225 PSMA, lutetium-177 PSMA | — | Multidisciplinary tumor board designs targeted therapy plans based on genetic profiling. Real-time AI-supported MRI and PET/CT track progress. Turkey's first JCI-accredited hospital. | — | ||
| #6 | 4.5 / 5 (55) | Istanbul, Turkey | — | — | PET/CT, Consultation with a neurosurgeon | — | — | Joint Commission International | |
| #7 | 4.4 / 5 (35) | Istanbul, Turkey | 76+ years | Ultrasound, MRI of one area | — | — | International Organization for Standardization, Joint Commission International | ||
| #8 | 4.9 / 5 (59) | Istanbul, Turkey | 23+ years | Lutetium-177 therapy, monoclonal antibody therapy, immunotherapy | Pancreatic neuroendocrine tumors | Offers specialized Lutetium-177 therapy and personalized treatment plans based on genetic testing. Doctors have performed 1,100+ procedures with a focus on gastrointestinal cancers. | Turkish Medical Association, International Health Tourism Authorization Certificate | ||
| #9 | 5.0 / 5 (1) | Istanbul, Turkey | — | — | MRI of one area, Premium Check up | — | — | International Organization for Standardization, Joint Commission International | |
| #10 | 4.7 / 5 (19) | Istanbul, Turkey | — | — | Intravenous administration, oral administration, mutation analysis, multidisciplinary tumor board | — | Molecular diagnostics and mutation analysis guide which targeted therapy is chosen, with complex cases reviewed by a Multidisciplinary Tumor Board. JCI-accredited, with on-site PET/CT and MRI. | International Organization for Standardization, Joint Commission International |